NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=130247&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your FMC Corporation (NYSE:FMC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fmc-corporation-lawsuit-submission-form?prid=130248&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=130262&wire=1 or contact Joseph E. Levi, Esq.

LOS ANGELES , Feb. 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Monolithic Power Systems, Inc. ("Monolithic Power" or "the Company") (NASDAQ: MPWR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 8, 2024 and November 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before April 7, 2025.

LOS ANGELES , Feb. 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ModivCare Inc. ("ModivCare" or "the Company") (NASDAQ: MODV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 3, 2022, and September 15, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 31, 2025.

Peter Lynch, one of my favorite investment “gurus,” lists 13 aspects of a “perfect” stock.

The GoPro Quik App Simplifies the 360 Mobile Editing Experience, Bringing AI Object Tracking, Keyframing, Digital Lens Options, Preset CameraFXs, Cloud-Hosted Edits and More to Your Phone Professional Video Editors Can Leverage the Magic of Reframe on Desktop with the 'GoPro Reframe' Plugin on Adobe Premiere Pro and After Effects SAN MATEO, Calif. , Feb. 18, 2025 /PRNewswire/ -- GoPro, Inc. (NASDAQ: GPRO) today announced a suite of new 360 offerings, starting with the reintroduction of a refreshed MAX 360 camera.

BOISE, Idaho, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), today announced the Micron 4600 PCIe® Gen5 NVMe™ SSD, an innovative client storage drive for OEMs that is designed to deliver exceptional performance and user experience for gamers, creators and professionals. Leveraging Micron® G9 TLC NAND, the 4600 SSD is Micron's first Gen5 client SSD and doubles the performance of its predecessor.1 The Micron 4600 SSD showcases sequential read speeds of 14.5 GB/s and write speeds of 12.0 GB/s.

RocketRentRewards is the first offer in the mortgage industry to provide up to $5,000 in closing cost credits for rent payments DETROIT , Feb. 18, 2025 /PRNewswire/ -- Rocket Mortgage, the nation's largest mortgage lender and a part of Rocket Companies (NYSE: RKT), today introduced RocketRentRewards – the homeownership industry's first offer to provide closing cost credits for renters. With a Rocket mortgage, homebuyers earn 10% back on the last 12 months of rental payments – receiving up to $5,000 in lender credits toward closing costs.

The introduction of the cutting-edge, chip-efficient AI chat model DeepSeek sent markets into a frenzy in late January, sparking an American AI sell-off. Featuring twice the computing power at a fraction of the cost of models like ChatGPT, the introduction of DeepSeek was particularly painful for chip manufacturer NVIDIA Co. NASDAQ: NVDA, whose shares fell more than 14% on the date of DeepSeek's introduction.

Investors interested in aerospace stocks may add ACHR to their portfolio, considering its low debt-to-capital ratio and upward revision in earnings estimate.

With AI-driven tailwinds, a differentiated product offering, solid cash flow generation and aggressive buybacks, TWLO presents an attractive buying opportunity.

Rivian Automotive RIVN is slated to release fourth-quarter 2024 results on Thursday, after market close. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a loss of 66 cents a share on revenues of $1.43 billion.

Wall Street was upbeat last week, despite the release of hot January inflation data.

Fluor (FLR) came out with quarterly earnings of $0.48 per share, missing the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.68 per share a year ago.

Visa's net revenue rose 10% YoY to $9.5B, with cross-border volume surging 16%, driven by global travel recovery. Tap to Pay penetration hit 74%, and tokenized credentials grew 44% YoY, reinforcing Visa's network effect and security. Strategic deals with ICBC (China) and SBI (India) position V for long-term growth in high-potential regions.

Demos highlight maturity and capability of Raytheon NGSRI solution TUCSON, Ariz. , Feb. 18, 2025 /PRNewswire/ -- Raytheon, an RTX (NYSE: RTX) business, announced a series of 10 successful subsystem demonstrations for the U.S. Army's Next-Generation Short-Range Interceptor (NGSRI), which will eventually replace the Stinger® surface-to-air missile.

HACKENSACK, NJ / ACCESS Newswire / February 18, 2025 / Champions Oncology Inc. (NASDAQ:CSBR), a global leader in preclinical oncology research and clinical specialty testing, today announced the acceptance of seventeen abstracts for presentation at the AACR Annual Meeting, in Chicago, IL (April 25-30, 2025). These presentations will highlight Champions' cutting-edge research, featuring innovative in vivo and organoid platforms for oncology and immuno-oncology drug testing, as well as AI-driven models that utilize multi-omics datasets to predict patient outcomes.

BOCA RATON, FL / ACCESS Newswire / February 18, 2025 / Greenlane Holdings, Inc. (NASDAQ:GNLN) (the "Company"), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of approximately $25.0 million of shares of Common Stock and investor warrants at a price of $1.19 per Common Unit. The entire transaction has been priced at the market under Nasdaq rules.

Priority Review Vouchers (PRVs) are transferable and, in past transactions by other companies, have sold for prices up to $350 million 1.3 to 4 million cholera cases and 21,000 to 143,000 cholera-related deaths occur each year worldwide SAN FRANCISCO, CA / ACCESS Newswire / February 18, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") and Jaguar family company Napo Pharmaceuticals ("Napo") today announced that, on January 29, 2025, they extended their collaboration with Streeterville related to Napo's plans to develop its NP-300 drug product candidate for the symptomatic relief of diarrhea and dehydration in cholera patients and pursue …